Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy M
published in: Arthritis & Rheumatology
date of publication: 2000-02-01
language: English
main subject: patient, osteoarthritis, placebo, endoscopy
Cites articles
There is nothing here
Article - wd:Q44062409